ReviewFrontiers in neuroscience2026
Closed-loop neuromodulation: a paradigm shift in precision neuroscience for clinical and cognitive applications.
Review in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Closed-loop neuromodulation systems are critically synthesized here with respect to their foundational principles, mechanistic underpinnings, and systematic classifications. This comprehensive survey covers their rapid research progress and expanding clinical applications, while rigorously exploring their emerging potential for cognitive augmentation. Concurrently, persistent challenges and future research directions are identified. The scope encompasses invasive, non-invasive, and peripheral techniques, with careful examination of their therapeutic utility in neurological and psychiatric disorders-including epilepsy, major depression, chronic pain syndromes, and movement disorders-alongside exploratory applications in cognitive enhancement among healthy individuals. Enabling technologies, such as advanced wireless biosensors, sophisticated AI-driven adaptive algorithms, and novel stimulation modalities, are critically assessed, juxtaposed with inherent challenges like robust biomarker validation, long-term device stability, and complex ethical considerations. Closed-loop neuromodulation systems have demonstrably achieved superior efficacy, enhanced personalization, and improved safety profiles compared to conventional open-loop paradigms. The accelerating pace of technological innovation is rapidly translating these advances from bench to bedside. This technology signifies a fundamental evolution in personalized medicine and offers substantial potential for cognitive optimization, necessitating concerted interdisciplinary collaboration to surmount extant challenges and ensure successful, responsible implementation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.